(Q33734828)

29 July 2017

1 reference

title

Hereditary endocrinopathies (English)

1 reference

29 July 2017

Moley JF

1

1 reference

29 July 2017

Lairmore TC

series ordinal

2

1 reference

29 July 2017

Phay JE

series ordinal

3

1 reference

29 July 2017

publication date

1 September 1999

1 reference

Current Problems in Surgery

29 July 2017

published in

1 reference

29 July 2017

volume

36

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

653-762

1 reference

The origin and development of human tumors studied with cell markers

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Isolation of a transforming sequence from a human bladder carcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Human-tumor-derived cell lines contain common and different transforming genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Structural organization of the bcr gene and its role in the Ph' translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The molecular genetics of Philadelphia chromosome-positive leukemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Chromosomal translocations in human cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Evidence for the recessive nature of cellular immortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Mutation of a mutL homolog in hereditary colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Genetic alterations during colorectal-tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Allelotype of colorectal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

APC mutations occur early during colorectal tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Gardner syndrome in a man with an interstitial deletion of 5q.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The use and interpretation of commercial APC gene testing for familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Genetic aspects of adenomatosis of endocrine glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Characterization of mutations in patients with multiple endocrine neoplasia type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The gastrinoma triangle: operative implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger-Ellison syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Characteristics of duodenal wall gastrinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Extrapancreatic, extraintestinal gastrinoma: effective treatment by surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Outcome of lymph node involvement in patients with the Zollinger-Ellison syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Stricture and perforation of the esophagus: overlooked threats in the Zollinger-Ellison syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Reflux esophagitis in patients with Zollinger-Ellison syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Neuroendocrine tumors of the pancreas and duodenum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Gastrinomas: localization by means of selective intraarterial injection of secretin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Zollinger-Ellison syndrome. Current concepts in diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Insulinomas: localization with selective intraarterial injection of calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Prospective study of provocative angiograms to localize functional islet cell tumors of the pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Insulinoma. The value of intraoperative ultrasonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Multiple endocrine neoplasia type 1: clinical and genetic topics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Carcinoids associated with multiple endocrine neoplasia syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Cause of death in multiple endocrine neoplasia type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Lethality of multiple endocrine neoplasia type I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Positional cloning of the gene for multiple endocrine neoplasia-type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Germline mutations in the multiple endocrine neoplasia type 1 gene: evidence for frequent splicing defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Characterization of the mouse Men1 gene and its expression during development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Genetic basis of endocrine disease 5. Molecular genetics of parathyroid gland neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Somatic mutation of the MEN1 gene in parathyroid tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndromes. Surgical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

MEN I pancreas: A histological and immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Operative tumour yield obviates preoperative pancreatic tumour localization in multiple endocrine neoplasia type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Experience with multiple endocrine neoplasia type 1 screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Multiple endocrine syndromes--a nightmare for the endocrinologic radiologist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The relationship of hereditary hyperparathyroidism to endocrine adenomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Familial benign hypercalcemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Familial benign hypercalcaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Vitamin D metabolism in familial benign hypercalcemia (hypocalciuric hypercalcemia) differs from that in primary hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Familial hypocalciuric hypercalcaemia: association with neonatal primary hyperparathyroidism, and possible linkage with HLA haplotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

High-resolution parathyroid sonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Familial benign hypercalcaemia: a possible abnormality in calcium transport by erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcaemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Mutations in the calcium-sensing receptor and their clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Familial hypocalciuric hypercalcemia associated with mutation in the human Ca(2+)-sensing receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Three inherited disorders of calcium sensing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Preliminary localization of a gene for autosomal dominant hypoparathyroidism to chromosome 3q13

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Familial hyperparathyroidism. Description of a large kindred with physiologic observations and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Jaw lesions in familial hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Parathyroid carcinoma in familial hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Fibroosseous tumors of the facial skeleton in association with primary hyperparathyroidism: An endocrine syndrome or coincidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Familial hyperparathyroidism associated with cementifying fibromas of the jaws in two siblings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Metastatic parathyroid carcinoma in the MEN2A syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Mutations of the RET proto-oncogene in Hirschsprung's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

C-Cell Hyperplasia Preceding Medullary Thyroid Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Medullary carcinoma of the thyroid gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma. Three-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Early liver metastases in patients with medullary carcinoma of the thyroid gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nationwide study of 249 patients in Sweden from 1959 through 1981

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Inherited Medullary Thyroid Carcinoma: A Final Monoclonal Mutation in One of Multiple Clones of Susceptible Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Activation of a novel human transforming gene, ret, by DNA rearrangement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Germline mutation of RET codon 883 in two cases of de novo MEN 2B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Mutations of theRET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Renal agenesis and the absence of enteric neurons in mice lacking GDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Defects in enteric innervation and kidney development in mice lacking GDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Renal and neuronal abnormalities in mice lacking GDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Functional receptor for GDNF encoded by the c-ret proto-oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

GDNF signalling through the Ret receptor tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Characterization of a multicomponent receptor for GDNF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

RET Mutation Screening in Familial Cutaneous Lichen Amyloidosis and in Skin Amyloidosis Associated With Multiple Endocrine Neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of the RET Proto-Oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

RET proto-oncogene mutations in French MEN 2A and FMTC families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Occurrence of MEN 2a in familial Hirschsprung's disease: a new indication for genetic testing of the RET proto-oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Multiple endocrine neoplasia type 2B: more than an endocrine disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

"Cold" single-strand conformational variants for mutation analysis of the RET protooncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Prognostic value of N-myc immunoreactivity in medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Loss of neurofibromatosis type I (NF1) gene expression in pheochromocytomas from patients without NF1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Relatively good prognosis of multiple endocrine neoplasia type 2B in Japanese: review of cases in Japan and analysis of genetic changes in tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Nuclear DNA content and survival in medullary thyroid carcinoma. Swedish Medullary Thyroid Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Somatostatin in medullary thyroid cancer. In vitro and in vivo studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Plasma somatostatin activity in medullary cancer of the thyroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The intratumoral immunoassayable somatostatin concentration is frequently elevated in medullary thyroid carcinoma. Results in 34 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The Early Diagnosis of Medullary Carcinoma of the Thyroid Gland in Patients with Multiple Endocrine Neoplasia Type II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Improved results of cervical reoperation for medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Nonfamilial medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Medullary thyroid carcinoma: prognostic factors and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Medullary thyroid carcinoma.Importance of serial serum calcitonin measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Detection of RET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: is parathyroid transplantation indicated?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Laparoscopic adrenalectomy. The importance of a flank approach in the lateral decubitus position

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Laparoscopic resection of pheochromocytoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

A comparison of laparoscopic and open adrenalectomies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocytoma and its precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Bilateral occurrence of pheochromocytoma in patients with the multiple endocrine neoplasia syndrome type 2A (Sipple's syndrome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Radioactive iodine in the treatment of medullary carcinoma of the thyroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Results of postoperative radiation therapy in medullary carcinoma of the thyroid: A retrospective study by the French Federation of Cancer Institutes - The Radiotherapy Cooperative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

The role of radiation therapy in medullary carcinoma of the thyroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Failure of Medullary Carcinoma of the Thyroid to Respond to Doxorubicin Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Von Hippel-Lindau disease: a genetic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Molecular genetic analysis of von Hippel-Lindau disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Identification of the von Hippel-Lindau disease tumor suppressor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Inhibition of transcription elongation by the VHL tumor suppressor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Pheochromocytoma in von Hippel-Lindau disease: clinical presentation and mutation analysis in a large, multigenerational kindred

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Management of pancreatic lesions in von Hippel-Lindau disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Neurofibromatosis type 1--an update and review for the primary pediatrician

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Tumour predisposition in mice heterozygous for a targeted mutation in Nf1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Evidence for Genetic Heterogeneity of the Carney Complex (Familial Atrial Myxoma Syndromes)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

7 January 2021

Inherited breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Identification of the breast cancer susceptibility gene BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Identification of FAP locus genes from chromosome 5q21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Identification and characterization of the familial adenomatous polyposis coli gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Germline p16 mutations in familial melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Genetic events in the development of Wilms' tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Mutations in the SMAD4/DPC4 gene in juvenile polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Deletion of genes on chromosome 1 in endocrine neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Deletion mapping of chromosome 1p and 22q in pheochromocytoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

Transplantation of the Parathyroid Glands: Current Status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Pancreatic lesions in the von Hippel-Lindau syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2899%2980001-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0011-3840(99)80001-X

1 reference

29 July 2017

1 reference